SCHEMBL27849652

SCHEMBL27849652

CC(COC=O)c1cncs1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
HRH1 P35367 1/20 0.32
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27967466 0.82 HDAC8 (0.33)
SCHEMBL27895547 0.81
SCHEMBL27869269 0.81
SCHEMBL28281155 0.78 HDAC8 (0.31)
SCHEMBL27861814 0.78
SCHEMBL27610224 0.78 PARP15 (0.30)
SCHEMBL28098380 0.77
SCHEMBL27764247 0.76 SLC6A3 (0.42) SLC6A2SLC6A4SLC6A3
SCHEMBL12310544 0.75
SCHEMBL2094497 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102428075-B crystalline tripeptide epoxy ketone protease inhibitors ONYX THERAPEUTICS, INC. (US) 2016-05-11 CN disclosed
CN-104968650-A Modified release formulations of Oprozomib ONYX THERAPEUTICS INC 2015-10-07 CN disclosed
CN-102414208-B Isoxazole-thiazole derivatives as GABAA a receptor inverse agonists for use in the treatment of cognitive disorders HOFFMANN LA ROCHE 2014-11-05 CN disclosed
CN-102428075-A Crystalline tripeptide epoxy ketone protease inhibitors ONYX THERAPEUTICS INC 2012-04-25 CN disclosed
CN-102414208-A Isoxazole-thiazole derivatives as inverse agonists of GABAA receptors for use in the treatment of cognitive disorders HOFFMANN LA ROCHE 2012-04-11 CN disclosed